RNA Sequencing Solves Genetic Puzzles Where DNA Analysis Fails

Standard exome and genome sequencing have transformed medicine, yet they often hit a wall when analysing non-coding regions of the DNA. These 'blind spots' include intronic variants and regulatory disruptions that DNA analysis alone cannot fully interpret. A new retrospective review of 30 cases from the Utah Penelope Program and the Undiagnosed Diseases Network illustrates how RNA sequencing (RNA-seq) is bridging this gap.

By examining RNA—the messenger molecule that carries genetic instructions—researchers identified critical functional errors that standard DNA tests missed. These included 'exon skipping', where necessary parts of the genetic code are omitted, and 'intron retention', where superfluous code is accidentally kept. The study also clarified complex X-inactivation patterns and dosage effects.

Crucially, these insights allowed clinicians to reclassify 'variants of uncertain significance' into definitive diagnoses. By visualising the actual transcript-level alterations, RNA-seq provided the missing evidence needed to solve these genetic mysteries. The findings advocate for integrating RNA analysis into clinical workflows to support genetic counselling and patient care when DNA sequencing yields inconclusive results.